Balance Sheet for Eloxx Pharmaceuticals Inc. (ELOX)

$ 3.60   0.10 (+2.86%) Volume: 118.83k 4:00 PM EDT 26-May-2020
After Hours:  $ 3.60 0.00 (0.00%) Volume: 994 4:00 PM EDT 26-May-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 06/2017 06/2016
Cash and Equivalents 22,493 48,606 24,049 33 811
Restrictable Cash 43 45 102 - -
Marketable Securities 33,783 - - - -
Accounts Receivable 403 - - - -
Loans Receivable - - - - -
Other Receivables 403 - - - -
Receivables 403 - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 1,364 1,670 267 251 172
Current Deferred Income Taxes - - - - -
Other Current Assets 26 20 88 - -
Total Current Assets 57,709 50,341 24,506 284 983
Land and Improvements - - - - -
Buildings and Improvement 158 141 53 - 10
Machinery, Furniture and Equipment 330 311 279 332 339
Construction in Progress - - - - -
Fixed Assets, Other 924 - - - -
Fixed Assets, Total 1,412 452 332 332 349
Gross Fixed Assets 1,412 452 332 332 349
Accumulated Depreciation (287) (204) (54) (281) (257)
Net Fixed Assets 1,125 248 278 51 93
Intangibles - - 16,500 5,500 8,100
Cost in Excess - - - - 8,762
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 113 129 - - -
Total Non-Current Assets 1,238 377 278 5,561 8,243
Total Assets 58,947 50,718 24,784 5,845 9,226
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 06/2017 06/2016
Accounts Payable 1,871 747 1,520 192 90
Short Term Debt 4,835 - - - -
Notes Payable - - 1,376 407 -
Accrued Expenses 4,655 6,938 1,893 320 247
Accrued Liabilities 4,655 6,938 1,893 320 247
Deferred Revenues 403 - - - -
Current Deferred Income Taxes - - - (1,040) (680)
Other Current Liabilities 43 122 (1,366) 1,855 32
Total Current Liabilities 11,807 7,807 3,423 2,774 369
Long Term Debt 10,502 N/A - N/A -
Deferred Income Tax - - 6,600 2,200 3,240
Other Non-Current Liabilities - - (6,604) (2) 1,054
Minority Interest - - - - -
Capital Lease Obligations 425 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 10,927 - (4) 2,200 4,296
Total Liabilities 22,734 7,807 3,419 4,974 4,665
Preferred Shareholder's Equity - - 4 2 2
Common Shareholder's Equity 36,213 42,911 21,361 870 4,558
Common Par 402 360 274 292 205
Additional Paid in Capital 174,515 129,825 60,047 122,402 119,983
Cumulative Translation Adjustments - - - - -
Retained Earnings (137,019) (86,145) (38,960) (121,824) (115,630)
Treasury Stock 1,703 1,129 - - -
Other Equity Adjustments 18 - - - -
Total Capitalization 46,715 42,911 21,365 871 4,561
Total Equity 36,213 42,911 21,365 871 4,561
Total Liabilities & Shareholder's Equity 58,947 50,718 24,784 5,845 9,226
Cash Flow (51,132) (47,185) (28,064) (6,194) (8,447)
Working Capital 45,902 42,534 21,083 (2,490) 614
Free Cash Flow (39,431) (31,602) (16,172) (1,928) (3,676)
Invested Capital 46,715 42,911 21,361 871 4,561
Shares Outstanding - Common Class Only 40,031 35,860 27,528 1,460 1,025
Preferred Shares Outstanding - - - - 235
Total Ordinary Shares 40,031 35,860 27,528 1,460 1,025
Total Common Shares Outstanding 40,031 35,860 27,528 1,460 1,025
Treasury Shares 156 91 - - -
Basic Weighted Shares Outstanding 38,063 32,437 4,976 1,161 1,016
Diluted Weighted Shares Outstanding 38,063 32,437 4,976 1,161 1,016